Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
4 Jan 2025
Metformin Does Not Affect Prostate Cancer Progression Rates
Despite promising preclinical and epidemiological data, metformin does not appear to impact disease progression in men with low-risk prostate cancer.
4 Jan 2025
Mailed Faecal Immunochemical Testing Boosts CRC Screening Rates
A centralised, mailed colorectal cancer screening programme significantly improved screening completion rates in federally qualified health centres.
3 Jan 2025
Immunotherapy Combination Shows Promise for Early-Stage
ERBB2
-Positive Breast Cancer
A recent Phase I clinical trial has provided promising results for a novel immunotherapy approach to treat early-stage ERBB2-positive breast cancer.
2 Jan 2025
New Metric Offers Insight into Red Blood Cell Function and Quality
A recent study has introduced FlowScore, a new metric for evaluating the quality of red blood cells that goes beyond traditional haemoglobin assays…
1 Jan 2025
Telemedicine-Based Exercise Programme Shows Promise for Cancer Survivors
A recent study examining the effectiveness of a telemedicine-based exercise programme for cancer survivors has shown encouraging results…
31 Dec 2024
Blood Pressure Fluctuations Linked to Cognitive Decline in Older Adults
A new study highlights the link between visit-to-visit blood pressure variability (BPV) and cognitive decline in older adults….
28 Dec 2024
Colorectal Cancer Rates Rising Among Younger Adults Globally
Colorectal cancer incidence among adults under 50 years is rising in 27 of 50 countries analysed, according to a new global study.
27 Dec 2024
Polygenic Risk Scores May Enhance Active Surveillance for Prostate Cancer
A recent study suggests multi-ancestry polygenic risk scores (PRS) may help refine active surveillance strategies for low- to intermediate-risk prostate cancer.
26 Dec 2024
Update on Riociguat for Patients with Sickle Cell Disease
This phase 1–2, randomised, double-blind, placebo-controlled trial enrolled 130 patients aged 18 or older with confirmed sickle cell disease.
26 Dec 2024
CRISPR-Based Cell Therapy Eliminates Crises in Patients with Sickle Cell Disease
In a phase 3 trial involving 44 patients aged 12 to 35, exa-cel was found to provide remarkable results….
←
1
2
3
…
82
83
84
85
86
87
88
…
105
106
107
→
We’ve noticed you’re accessing
from
North/South America.
View
View